tweenvest

Diamyd Medical AB (publ) (OM: DMYD B)

Health Care · Biotechnology · SE

Skr0.90

-2.82% today · -90.6% 1Y

Public summary
A free snapshot of Diamyd Medical AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Diamyd Medical AB (publ) (OM: DMYD B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.74M.

Over the last twelve months the share price has lost 90.6%, trading between 0.90 and 17.88.

Tweenvest scores Diamyd Medical AB (publ) across four factors: quality 35/100, value 53/100, growth 53/100. Its strongest factor is value.

DMYD B price history

Nov 21, 2025 · 9.11Weekly closes 0.90 – 17.00Nov 16, 2026 · 0.90

Key figures

Market cap
$13.74M
Revenue (TTM)
$49.79K
P/E
-0.50
EPS
-1.76
Dividend yield
—
Beta (5Y)
2.14
52-week high
Skr17.88
52-week low
Skr0.90
Avg volume (3M)
—
Shares outstanding
154.98M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Shaperon Inc.KOSDAQ: A378800$13.98M₩2,020.00-1.94%
Kyntra Bio, Inc.NasdaqGS: KYNB$13.93M$3.44-4.18%
Inhibitor Therapeutics, Inc.OTCPK: INTI$13.90M$0.08+1.27%
Allarity Therapeutics, Inc.NasdaqCM: ALLR$13.87M$0.87+3.69%
Passage Bio, Inc.NasdaqCM: PASG$13.68M$4.25+5.99%
TaiwanJ Pharmaceuticals Co., Ltd.TPEX: 6549$13.56MNT$5.94-4.19%
Akari Therapeutics, PlcNasdaqCM: AKTX$13.03M$5.70-12.44%
Pluri Inc.NasdaqCM: PLUR$12.96M$1.05-3.67%

Browse every Biotechnology company →